Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy N C Wells

Showing results (41-50 of 70) with videos related to

Pageof 7
Sort By:
Malaria Journal|October 1, 2025
Making the most of existing antimalarial medicines: a single dose cure with sulfadoxine-pyrimethamine plus artesunate-pyronaridineGhyslain Mombo-Ngoma, Michael Ramharter, Rella Zoleko Manego, et al.
Frontiers in Immunology|October 23, 2012
Glycosaminoglycan analogs as a novel anti-inflammatory strategyIndia C Severin, Adriano Soares, Jennifer Hantson, et al.
Plos One|January 7, 2014
Anticancer properties of distinct antimalarial drug classesRob Hooft van Huijsduijnen, R Kiplin Guy, Kelly Chibale, et al.
The Journal of Biological Chemistry|July 21, 2007
Molecular cloning and characterization of a highly selective chemokine-binding protein from the tick Rhipicephalus sanguineusAchim Frauenschuh, Christine A Power, Maud Déruaz, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 11, 2003
Inhibition of airway inflammation by amino-terminally modified RANTES/CC chemokine ligand 5 analogues is not mediated through CCR3Yolande Chvatchko, Amanda E I Proudfoot, Raphaële Buser, et al.
Malaria Journal|November 3, 2018
Injectable anti-malarials revisited: discovery and development of new agents to protect against malariaFiona Macintyre, Hanu Ramachandruni, Jeremy N Burrows, et al.
Malaria Journal|October 18, 2024
Chemoprevention of malaria with long-acting oral and injectable drugs: an updated target product profileMyriam El Gaaloul, Andre Marie Tchouatieu, Kassoum Kayentao, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 5, 2022
Molnupiravir combined with different repurposed drugs further inhibits SARS-CoV-2 infection in human nasal epithelium in vitroHulda R Jonsdottir, Denise Siegrist, Thomas Julien, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 4, 2010
Kinetics of chemokine-glycosaminoglycan interactions control neutrophil migration into the airspaces of the lungsYoshi Tanino, Deirdre R Coombe, Sean E Gill, et al.
Clinical Microbiology Reviews|April 28, 2017
Susceptibility Testing of Medically Important ParasitesAbebe Genetu Bayih, Anjan Debnath, Edward Mitre, et al.
Pageof 7

Showing results (41-50 of 70) with videos related to

Sort By:
Pageof 7
Malaria Journal|October 1, 2025
Making the most of existing antimalarial medicines: a single dose cure with sulfadoxine-pyrimethamine plus artesunate-pyronaridineGhyslain Mombo-Ngoma, Michael Ramharter, Rella Zoleko Manego, et al.
Frontiers in Immunology|October 23, 2012
Glycosaminoglycan analogs as a novel anti-inflammatory strategyIndia C Severin, Adriano Soares, Jennifer Hantson, et al.
Plos One|January 7, 2014
Anticancer properties of distinct antimalarial drug classesRob Hooft van Huijsduijnen, R Kiplin Guy, Kelly Chibale, et al.
The Journal of Biological Chemistry|July 21, 2007
Molecular cloning and characterization of a highly selective chemokine-binding protein from the tick Rhipicephalus sanguineusAchim Frauenschuh, Christine A Power, Maud Déruaz, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 11, 2003
Inhibition of airway inflammation by amino-terminally modified RANTES/CC chemokine ligand 5 analogues is not mediated through CCR3Yolande Chvatchko, Amanda E I Proudfoot, Raphaële Buser, et al.
Malaria Journal|November 3, 2018
Injectable anti-malarials revisited: discovery and development of new agents to protect against malariaFiona Macintyre, Hanu Ramachandruni, Jeremy N Burrows, et al.
Malaria Journal|October 18, 2024
Chemoprevention of malaria with long-acting oral and injectable drugs: an updated target product profileMyriam El Gaaloul, Andre Marie Tchouatieu, Kassoum Kayentao, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 5, 2022
Molnupiravir combined with different repurposed drugs further inhibits SARS-CoV-2 infection in human nasal epithelium in vitroHulda R Jonsdottir, Denise Siegrist, Thomas Julien, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 4, 2010
Kinetics of chemokine-glycosaminoglycan interactions control neutrophil migration into the airspaces of the lungsYoshi Tanino, Deirdre R Coombe, Sean E Gill, et al.
Clinical Microbiology Reviews|April 28, 2017
Susceptibility Testing of Medically Important ParasitesAbebe Genetu Bayih, Anjan Debnath, Edward Mitre, et al.
Pageof 7